In 2005, Marzesco and colleagues were the first to report the release of CD133 into the external environment; they described its release both in physiological fluids, notably cerebrospinal fluid and urine, and in conditioned medium of a cancer cell line in culture [191]. The gene discussed is PROM1; the disease is cancer.